Alberta Impact is proud to work with Health Cities to bring you this ten episode series highlighting Alberta based health innovators, collaborations and partnerships that are working to mold the "Future of Health".
Fusogenix an Effective Drug Delivery
Dr. John Lewis's biotechnology company develops next generation nucleic acid medicines and they just announced their development of a Fusogenix DNA vaccine to prevent COVID-19 infections. Hear more on what are some of the other advantages of this DNA vaccine even for cancerous cells.
Connect with Entos Pharmaceutical: https://www.entospharma.com/
Connect with Dr. John Lewis: https://apcari.ca/meet-the-team/john-d-lewis-research-group/